To determine the mechanism of action of X15695, we first performed transcriptomics analyses in the ER+ breast cancer cell lines MCF-7 and T47D after treating them with vehicle (DMSO), 17-β-estradiol (E2), X15695, and a combination of E2 and X15695. Here, ESR1 is linked to breast carcinoma.